Genesis Healthcare (NYSE:GEN) Shares Pass Above 200 Day Moving Average of $1.23

Genesis Healthcare Inc (NYSE:GEN)’s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.23 and traded as high as $1.18. Genesis Healthcare shares last traded at $1.18, with a volume of 2,826 shares.

The stock’s fifty day moving average price is $1.15 and its two-hundred day moving average price is $1.23. The company has a market capitalization of $194.44 million, a PE ratio of -0.76 and a beta of 0.92.

Genesis Healthcare (NYSE:GEN) last posted its earnings results on Thursday, August 8th. The company reported ($0.05) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.13) by $0.08. The firm had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter in the prior year, the company posted ($0.39) earnings per share. On average, equities analysts expect that Genesis Healthcare Inc will post -0.46 earnings per share for the current fiscal year.

Several institutional investors have recently bought and sold shares of the company. Aptus Capital Advisors LLC purchased a new stake in Genesis Healthcare in the second quarter worth about $145,000. SG Americas Securities LLC lifted its holdings in Genesis Healthcare by 64.0% in the second quarter. SG Americas Securities LLC now owns 50,954 shares of the company’s stock worth $63,000 after buying an additional 19,889 shares during the period. Claraphi Advisory Network LLC purchased a new stake in Genesis Healthcare in the second quarter worth about $75,000. Renaissance Technologies LLC lifted its holdings in Genesis Healthcare by 9.1% in the second quarter. Renaissance Technologies LLC now owns 3,674,111 shares of the company’s stock worth $4,556,000 after buying an additional 307,700 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in Genesis Healthcare by 23.5% in the second quarter. Vanguard Group Inc. now owns 2,926,435 shares of the company’s stock worth $3,628,000 after buying an additional 557,039 shares during the period. Institutional investors own 20.78% of the company’s stock.

About Genesis Healthcare (NYSE:GEN)

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

See Also: What Factors Can Affect Return on Equity?

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.